科研製薬の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2012/12/07 | 1,303 | 1,303 | 1,293 | 1,294 | -9 | -0.7% | 158,000 |
| 2012/12/06 | 1,298 | 1,308 | 1,294 | 1,303 | +14 | +1.1% | 220,000 |
| 2012/12/05 | 1,299 | 1,303 | 1,288 | 1,289 | -9 | -0.7% | 285,000 |
| 2012/12/04 | 1,300 | 1,306 | 1,291 | 1,298 | +5 | +0.4% | 211,000 |
| 2012/12/03 | 1,287 | 1,306 | 1,287 | 1,293 | +2 | +0.2% | 222,000 |
| 2012/11/30 | 1,309 | 1,318 | 1,287 | 1,291 | -11 | -0.8% | 310,000 |
| 2012/11/29 | 1,282 | 1,307 | 1,279 | 1,302 | +18 | +1.4% | 310,000 |
| 2012/11/28 | 1,256 | 1,290 | 1,256 | 1,284 | +23 | +1.8% | 270,000 |
| 2012/11/27 | 1,243 | 1,266 | 1,243 | 1,261 | +8 | +0.6% | 342,000 |
| 2012/11/26 | 1,251 | 1,266 | 1,243 | 1,253 | -5 | -0.4% | 230,000 |
| 2012/11/22 | 1,275 | 1,275 | 1,253 | 1,258 | -11 | -0.9% | 280,000 |
| 2012/11/21 | 1,282 | 1,284 | 1,268 | 1,269 | -20 | -1.6% | 279,000 |
| 2012/11/20 | 1,298 | 1,298 | 1,281 | 1,289 | -4 | -0.3% | 191,000 |
| 2012/11/19 | 1,279 | 1,294 | 1,278 | 1,293 | +19 | +1.5% | 133,000 |
| 2012/11/16 | 1,275 | 1,277 | 1,261 | 1,274 | +1 | +0.1% | 205,000 |
| 2012/11/15 | 1,273 | 1,288 | 1,270 | 1,273 | -24 | -1.9% | 209,000 |
| 2012/11/14 | 1,265 | 1,299 | 1,255 | 1,297 | +32 | +2.5% | 263,000 |
| 2012/11/13 | 1,250 | 1,266 | 1,248 | 1,265 | +12 | +1% | 160,000 |
| 2012/11/12 | 1,261 | 1,269 | 1,251 | 1,253 | -19 | -1.5% | 162,000 |
| 2012/11/09 | 1,279 | 1,283 | 1,271 | 1,272 | -16 | -1.2% | 98,000 |
| 2012/11/08 | 1,291 | 1,300 | 1,280 | 1,288 | -7 | -0.5% | 258,000 |
| 2012/11/07 | 1,285 | 1,305 | 1,282 | 1,295 | +19 | +1.5% | 366,000 |
| 2012/11/06 | 1,248 | 1,278 | 1,237 | 1,276 | +28 | +2.2% | 198,000 |
| 2012/11/05 | 1,251 | 1,257 | 1,246 | 1,248 | -10 | -0.8% | 135,000 |
| 2012/11/02 | 1,241 | 1,259 | 1,241 | 1,258 | +17 | +1.4% | 109,000 |
| 2012/11/01 | 1,233 | 1,249 | 1,228 | 1,241 | +4 | +0.3% | 263,000 |
| 2012/10/31 | 1,229 | 1,246 | 1,215 | 1,237 | +4 | +0.3% | 187,000 |
| 2012/10/30 | 1,235 | 1,246 | 1,233 | 1,233 | -7 | -0.6% | 160,000 |
| 2012/10/29 | 1,245 | 1,258 | 1,239 | 1,240 | -16 | -1.3% | 130,000 |
| 2012/10/26 | 1,250 | 1,259 | 1,244 | 1,256 | -6 | -0.5% | 223,000 |
| 2012/10/25 | 1,228 | 1,263 | 1,228 | 1,262 | +34 | +2.8% | 540,000 |
| 2012/10/24 | 1,225 | 1,229 | 1,210 | 1,228 | +16 | +1.3% | 369,000 |
| 2012/10/23 | 1,211 | 1,218 | 1,202 | 1,212 | +7 | +0.6% | 204,000 |
| 2012/10/22 | 1,192 | 1,209 | 1,192 | 1,205 | +6 | +0.5% | 181,000 |
| 2012/10/19 | 1,210 | 1,215 | 1,197 | 1,199 | -19 | -1.6% | 146,000 |
| 2012/10/18 | 1,200 | 1,219 | 1,198 | 1,218 | +29 | +2.4% | 280,000 |
| 2012/10/17 | 1,177 | 1,197 | 1,177 | 1,189 | +21 | +1.8% | 188,000 |
| 2012/10/16 | 1,172 | 1,176 | 1,162 | 1,168 | -1 | -0.1% | 196,000 |
| 2012/10/15 | 1,175 | 1,180 | 1,164 | 1,169 | -7 | -0.6% | 156,000 |
| 2012/10/12 | 1,178 | 1,186 | 1,173 | 1,176 | +6 | +0.5% | 150,000 |
| 2012/10/11 | 1,157 | 1,178 | 1,154 | 1,170 | +11 | +0.9% | 228,000 |
| 2012/10/10 | 1,172 | 1,180 | 1,157 | 1,159 | -20 | -1.7% | 189,000 |
| 2012/10/09 | 1,177 | 1,191 | 1,177 | 1,179 | +3 | +0.3% | 200,000 |
| 2012/10/05 | 1,180 | 1,193 | 1,174 | 1,176 | +8 | +0.7% | 301,000 |
| 2012/10/04 | 1,157 | 1,170 | 1,151 | 1,168 | +17 | +1.5% | 229,000 |
| 2012/10/03 | 1,159 | 1,159 | 1,143 | 1,151 | -8 | -0.7% | 170,000 |
| 2012/10/02 | 1,166 | 1,168 | 1,156 | 1,159 | -9 | -0.8% | 185,000 |
| 2012/10/01 | 1,167 | 1,170 | 1,147 | 1,168 | +2 | +0.2% | 261,000 |
| 2012/09/28 | 1,181 | 1,181 | 1,159 | 1,166 | -11 | -0.9% | 198,000 |
| 2012/09/27 | 1,161 | 1,184 | 1,161 | 1,177 | +5 | +0.4% | 215,000 |
3051～
3100
件表示中 / 3714件
類似銘柄と比較する
現在ご覧いただいている「科研薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 科研薬 | 377,300円 | -6.4% | -71.8% | 5.04% | 42.02倍 | 0.94倍 |
|
旧理研グループの名門。導入の関節機能改善剤、自社創製の爪白癬症薬の２本柱。後発品も展開 |
| キッセイ薬 | 423,500円 | +3.6% | +6.1% | 2.83% | 14.27倍 | 0.84倍 |
|
医薬品中堅。泌尿器、腎・透析、未充足医療が重点領域。主軸特許切れ、新しい柱育成。海外は導出 |
| 鳥居薬 | 634,000円 | +7.1% | -35.0% | 0.00% | 52.42倍 | 1.46倍 |
|
ＪＴ傘下。柱の抗ＨＩＶ薬販売権喪失後、自社製品の腎・透析、アレルゲン等の開発強化 |
| 東和薬品 | 319,000円 | +7.9% | -3.3% | 2.51% | 8.87倍 | 0.91倍 |
|
後発医薬品メーカーで国内２強の一角。循環器系に強い。直販軸に発展も卸との取引を拡大中 |
| ゼリア新薬 | 205,700円 | +3.1% | -6.5% | 2.33% | 9.54倍 | 1.01倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
市場注目の銘柄
チャート関連のコラム
